A previous genetic investigation involving a mouse-nonvirulent Salmonella abony donor (high frequency of recombination) and a virulent S. typhimurium recipient indicated that two unlinked "low-virulence" loci determined nonvirulence. A nonvirulent recombinant was analyzed to determine the basis for its nonvirulence. The recombinant was smooth (like the parental strains) and prototrophic. The doubling time in mouse serum of the recombinant and the S. abony parent (both streptomycin-resistant) was longer than that of the wild-type streptomycin-sensitive ancestor of the S. typhimurium recipient. The virulent recipient also grew poorly in serum. However, the nonvirulence of the recombinant was probably not due to its inheritance of the streptomycin-resistance allele from the donor, because other recombinants were streptomycin-resistant but still virulent. Unlike the nonvirulent S. abony (but like the S. typhimurium), the recombinant was insusceptible to rapid intravenous clearance in normal mice. It therefore appears that neither of the "low-virulence" loci determine iminished virulence by enhancing phagocytosis. Clearance of the recombinant was enhanced by opsonization with immune serum. Counts of viable bacteria in the blood, liver, and spleen of normal mice after intravenous challenge showed that the recombinant, like the S. abony donor, failed to proliferate in the tissues, whereas the virulent S. typhimurium did so markedly. It is concluded that the nonproliferation of the recombinant was determined by one or both of the "low-virulence" loci from the nonvirulent S. abony donor.
There are two regions of the bacterial chromosome which specify nonvirulence for mice (i.e., inability to kill with a few bacteria) of a smooth strain of Salmonella abony (11) . This was inferred from the segregation of nonvirulence in crosses between the nonvirulent strain of S. abony (LD6o = 108 bacteria intraperitoneally) as the chromosomal Hfr (high frequency of recombination) donor and a virulent strain of S. typhimurium (LD5o = <50 bacteria) as the recipient (F-). One nonvirulence locus was mapped between the gene for inositol fermentation (inl) and the gene controlling one of the steps in the biosynthesis of methionine (metA), and the other was mapped between the gene controlling highlevel resistance to streptomycin (strA) and one of the genes (aroD) specifying the biosynthesis of aromatic amino acids (11, 14, 17 This paper compares various characteristics of a completely nonvirulent Salmonella recombinant with those of its parental strains, in an attempt to understand the physiological basis of its nonvirulence.
MATERIALS AND METHODS Culture media. Nutrient broth consisted of Lablemco Beef Extract (Oxoid), 0.5%; Bacto-Peptone (Difco), 1%; and NaCl, 0.5%. Nutrient agar was nutrient broth solidified with 2% agar (Difco).
Diluent. Phosphate buffer (0.1 M, pH 7.4) was used.
Bacterial strains. Table 1 shows the characteristics ofthe strains used. All the strains have the KauffmannWhite 0 antigens 1, 4, 5, and 12. S. abony SW1444 is an Hfr strain and probably identical to S. abony SW1391 (13) . S. typhimurium CS is the mouse-virulent prototrophic wild-type strain described previously (6) . S. typhimurium M206 is mouse-nonvirulent and sensitive to the bactericidal action of serum (12) . S. (17) : his, metA, and aroD denote genes determining biosynthesis of histidine, methionine, and aromatic amino acids (tyrosine and phenylalanine), respectively; inl, rha, and ara denote genes specifying utilization of inositol, rhamnose, and arabinose, respectively; strA denotes gene controlling streptomycin resistance (1 mg/ml); HI and H2 denote genes specifying synthesis of flagellar antigens of phase 1 and phase 2, respectively; + = ability to synthesize or utilize; -= inability to synthesize or utilize; r = resistance; s = sensitivity. typhimurium C5P is a double mutant selected from C5 and previously described as C5 his ara (11) . C5R is the completely nonvirulent recombinant obtained by recombination between SW1444 as donor and C5P as recipient (11) . It was derived as follows. A recombinant selected for the donor his+ allele also inherited the donor strA resistance allele. Its virulence was intermediate between that of the donor and the recipient (LDIo = 105 bacteria), as previously reported (11).
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This recombinant was then crossed with the S. abony donor, selection being made for the rha+ allele of the donor. C5R, the rha+ recombinant from this backcross, also inherited the inl+ and HI-b loci from the donor as unselected markers. Its mouse virulence was similar to that of the donor (LD6o = 108 bacteria, i.e., nonvirulent), as previously reported (11) . The recipient alleles still present in the recombinant were ara and H2-1, 2. This strain will be referred to as recombinant C5R. S. paratyphi B Lister was the strain used in the Institute for Medical Research, Kuala Lumpur, for the preparation of typhoid-paratyphoid vaccine.
Preparation of bacterial cultures. Nutrient broth cultures, incubated for 18 hr at 37 C without shaking, were used in all experiments.
Mice. Random-bred Swiss white mice (of both sexes) weighing 18 to 22 g, obtained from the Institute for Medical Research, Kuala Lumpur, were used.
Mouse virulence of bacterial strains. Broth cultures were diluted and 0.2-ml dilutions were injected intraperitoneally into groups of 10 mice. The mice were housed in groups of 10. Mortality was recorded daily for 28 days, and the LD5o dose was calculated (15) .
Clearance of viable bacteria from the mouse bloodstream. The technique was similar to that described previously (1, 9) , except that recovery of viable bacteria was measured rather than recovery of uP label.
Heparin was not used, because it has been reported that there is no significant difference in the rate of clearance of bacteria in normal and heparinized mice (1) . A sample (0.2 ml) of a broth culture was injected into a tail vein (5 X 107 to 10 X 107 bacteria/mouse). At intervals, 0.05 ml of blood was obtained from the retro-orbital venous plexus with a calibrated glass pipette, diluted, and plated in duplicate on nutrient agar. For each bacterial strain, the logarithm of the arithmetic mean of the counts from three to five mice for a particular time was plotted against time, and the best-fit straight line through the points was calculated; its slope, which measures the rate of clearance, is the "phagocytic index" (K) and may alternatively be calculated from the equation K = (log,oC, -log1oC2)/ (T2-T1), where Cl and C2 are the counts at times T1 and T2 in minutes (9) . The calculations were made by using an IBM360 model 50 computer at Stanford University School of Medicine. The K values are expressed with two standard errors of the slope. In control experiments, it was determined that the percentage recovery of viable bacteria immediately after inoculation (assuming a mouse blood volume of 2 ml) was 75 to 95% of the inoculum.
Mouse serum. Normal mice were bled from the retro-orbital venous plexus and the blood was pooled. After clotting, the serum was collected by centrifugation and stored at -20 C. To obtain immune mouse serum, animals were inoculated intraperitoneally with 106 viable bacteria of the immunizing strain, and were bled 2 weeks later.
Opsonization of bacteria. One milliliter of undiluted immune serum and an equal volume of broth culture were mixed and held at 4 C; after 20 min, 0.4 ml of this mixture was inoculated intravenously into mice and the rate of clearance was determined as described.
Immune mice. Mice were inoculated intraperitoneally with 101 viable bacteria of the nonvirulent strain C5R. Twelve days later they were used in clearance tests.
Liver and spleen counts. Groups of mice were inoculated intravenously in the tail vein with 5 X 106 to 10 X 106 bacteria/mouse. At intervals, three mice for each bacterial strain were killed and their livers and spleens were removed aseptically. They were homogenized at 2,000 rev/min for 60 to 90 sec in a Stir-R tissue homogenizer (Tri-R Instruments, Jamaica, N.Y. Table 1 were tested with the phages used in B. A. D. Stocker's laboratory. The parental strains C5P and SW1444, and the recombinant C5R, were fully smooth (Table 2) , as were C5 (wildtype ancestor of C5P) and S. paratyphi B Lister. The insensitivity of strain Lister to phages P22 and P22h was presumed to be due to its lysogeny. Strain M206 was sensitive to several roughspecific phages, which suggests that this strain was at least partly rough.
Growth rate in normal mouse serum. Certain streptomycin-resistant mutants of a mousevirulent strain of S. typhimurium have a 3 to 7 min longer doubling time in nutrient broth, and are less virulent than the parent (7) . One such mutant was found to be less capable of proliferation in the mouse than was the virulent parent (7) . We therefore tested the recombinant and the parental Salmonella to determine whether they differed in growth rate, since the virulent parent C5P was streptomycin-sensitive, whereas the other parent, SW1444, and the recombinant, C5R, were both nonvirulent and streptomycinresistant. Growth in mouse serum would be a closer analogy to growth in the host than growth in nutrient broth, and so normal mouse serum was used at two concentrations (90 and 10%), with the 90% concentration approximating whole serum. For comparison with the auxotrophic derivative C5P, the streptomycin-susceptible wild-type C5 was also tested. Figure 1 shows the growth curves and the calculated doubling times. Growth in 10% mouse serum (in phosphate buffer) was slower and the final yield less than in 90% serum for all four Salmonella strains. The histidine-requiring C5P, though mouse-virulent, did not grow well in mouse serum (decrease in growth rate when viable count reached about 108), probably because of limitation of histidine in mouse serum (on addition of histidine, C5P grew normally). The doubling times in 90% serum were: C5P (streptomycin-sensitive, histidine-requiring, virulent), 33 min (in serum supplemented with histidine); C5 (streptomycin-sensitive, prototrophic, virulent), 27 min; C5R (streptomycinresistant, prototrophic, nonvirulent), 34 min; SW1444 (streptomycin-resistant, methionine-, phenylalanine-, and tyrosine-requiring, nonvirulent), 43 min.
Rate of clearance from the blood in normal mice. Soon after intravenous inoculation of certain nonvirulent Salmonella into normal mice, the bacteria are rapidly removed from the circulation, whereas virulent Salmonella are only slowly cleared (3, 9) . The rates of clearance of the recombinant and parental Salmonella strains were therefore tested in normal mice. It was expected that the nonvirulent recombinant C5R and the nonvirulent parent SW1444, but not the virulent parent C5P, would be rapidly phagocytized. Figure 2 shows the clearance of these 
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a Nutrient agar plates were surface-inoculated and spotted with 0.01 ml of phage lysate (108 plaqueforming units/ml). The plates were incubated at 37 C and examined at 5 min after abony parent SW1444, though smooth, was counts of rapidly cleared (K = 0.137), whereas the virulent )hagocytic parent C5P was not (K = 0.015). However, conirulent S. trary to expectation, the nonvirulent recombinant C5R was not rapidly cleared (K = 0.007). Before the significance of this result could be assessed,
two points had to be considered. First, it was in(0258hr) possible that the mice used in these tests were (205-8 " somehow different from mice used by other in-(4"-8' vestigators. Second, the rate of clearance determined by enumeration of viable bacteria may differ from those determined by using the 32p label technique described by Jenkin (8) . The rates of clearance of the S. typhimurium strains C5 and M206, which had previously been charin acterized by 32p label-monitoring in other mice (8) , were therefore examined with the mice used ni in these studies by enumeration of viable bacteria (Fig. 2) The clearance of such a strain (S. paratyphi B strain Lister) is shown in Fig. 2 ; like C5R, it was very slowly cleared (K = 0.010). Effect of antibody on rate of clearance. The slow clearance of some bacteria from the mouse circulation results from absence of antibody (1, 8) . The slow elimination of C5P and C5R 0137+0.043 might therefore be due to the absence of anti-01630036 body directed against these strains in the serum of normal mice. To test this, the clearance in normal mice of bacteria opsonized by prior exposure to immune mouse serum was examined ialmonella. (Table 3) . For comparative purposes, the K *, strain values (from Fig. 2 ) of nonopsonized bacteria 0, strain were also included. Untreated cells of strains C5P and C5R were scarcely cleared in 5 miin (Fig. 2) , and so clearance was examined over a longer period (Fig. 3) . The rates of clearance of C5P and C5R differed only slightly from those obtained over the 5-min period (C5P, K = 0.015 for 5 min and 0.015 for 30 min; C5R, K = 0.007 for 5 min and 0.016 for 30 min). With both strains, however, only about 30% of the bacteria remained in the mouse's circulation at 30 min. In contrast, 99% of the bacteria of the nonvirulent parent SW1444 had been cleared by 30 min. (Two K values for SW1444 are recorded, since the rate decreased after 10 min.)
Blood counts of recombinant and parental Salmonella over a long period of time. As the clearance of the virulent parent C5P and the nonvirulent recombinant C5R did not differ over a 30-min period, viable counts were made over a considerably longer period (Fig. 4) . The geometric mean of counts from five mice at each time period are shown. For all three Salmonella strains, the number of viable bacteria per milliliter of blood decreased in the first few hours after introduction. Even strains C5P and C5R, which were scarcely phagocytized initially ( Fig. 2  and 3 ), slowly disappeared from the circulation, with less than 5 % remaining 2 hr after challenge. The decrease in blood viable count terminated by 6 hr. From this time onwards, the behavior of the three Salmonella strains was quite different. The virulent parent C5P rapidly increased in numbers in the blood till it reached 107 bacteria/ ml, 30 to 36 hr after challenge, by which time nearly all the remaining challenged mice died. In the case of the nonvirulent recombinant C5R, there was little change in the blood viable count till 48 to 72 hr. In mice challenged with the nonvirulent donor parent SW1444, the bacterial population in the blood did not increase appreciably. While these experiments were in progress, groups of mice (15 per strain) that were similarly challenged were set aside to determine cumulative mortality (Fig. 4) of maximum mortality coincided with the appearance of large numbers of bacteria in the blood.
To determine whether the absolute number of bacteria inoculated intravenously affected subsequent events in the blood, mice were inoculated with 5 Fig. 4 ). The results (Fig. 5) showed that all three Salmonella strains were removed from the circulation by 24 hr (count reduced to <1% of initial level), but by 48 hr there was a divergence in the behavior of the strains. In mice inoculated with the virulent strain C5P, the numbers of viable bacteria in the blood increased rapidly, by 72 hr exceeding 106 bacteria/ ml, and all the mice died within 96 hr of inoculation. In mice inoculated with the nonvirulent C5R, small numbers of bacteria were recoverable till 72 hr, after which time blood samples were sterile (<20 bacteria/ml) till the end of the experiment (day 13). Most mice challenged with the nonvirulent SW1444 gave sterile blood cultures after 24 hr.
Recovery of viable bacteria of the recombinant and parental Salmonella in the liver and spleen. The phagocytic cells of the reticuloendothelial system (RES) in the liver and the spleen are principally responsible for the removal of bacteria from the blood (1, 2) . It was therefore of interest to study the counts of viable bacteria in the liver and spleen of intravenously inoculated mice (Fig. 6 and 7) . nonvirulent parent SW1444 failed to increase in number in the liver. A similar situation prevailed in the spleen except for a small increase in the first 24 hr after inoculation. The recombinant C5R appeared to fare a little better than SW1444 between days 1 and 4 in the spleen. Both nonvirulent strains were present in low numbers in the liver (<500 bacteria/liver) by the 10th day, and in the spleen by the 16th day ( < 100 bacteria/ spleen). The significant point is that, when equivalent numbers of bacteria were introduced intravenously, the virulent strain C5P had multiplied within 72 hr to population levels 1,000-fold greater than the nonvirulent strains.
DISCUSSION
The lack of mouse virulence of certain strains of, for instance, S. typhimurium, results from known causes, such as a requirement for growth factors (e.g., adenine) which are absent from mouse tissue (6), or from roughness which is known to determine extreme susceptibility to phagocytosis (4) . In other cases, the cause of lack of virulence is not apparent. An earlier investigation (11) concerned the genetic determination of the nonvirulence (LD5O = 108 bacteria by intraperitoneal inoculation) of a strain of S. abony which is smooth and which has an 0-antigenic formula identical with that of a mouse virulent strain of S. typhimurium (LD5o = <50 bacteria). In crosses of an Hfr derivative of this S. abony strain with the mouse virulent F S. typhimurium, the degree of virulence of recombinants suggested that the S. abony strain carried "low-virulence" genes in two regions of the chromosome. The present report describes experiments designed to allow examination of the physiological basis of nonvirulence of the S. abony strain, by comparing the behavior in various tests of the two parental strains and a recombinant which was as nonvirulent as the S. abony donor.
The results of phage sensitivity tests showed that the nonvirulent S. abony parent SW1444 and the nonvirulent recombinant C5R were fully smooth, like the virulent S. typhimurium parent C5P (Table 2 ). All three strains were also resistant to the bactericidal action of normal human serum (unpublished data); results of this test have been interpreted as indicating a possible correlation between mouse virulence and insusceptibility to human serum (16) . In contrast to the three strains mentioned above, the nonvirulent S. typhimurium strain M206 is sensitive to certain rough-specific phages (Table 2) , and both this strain and S. paratyphi B Lister are very sensitive to killing by human serum (unpublished data); these results suggest possible causes of their nonvirulence.
Hobson (7) found that mutants of S. typhimurium which are highly resistant to streptomycin grew more slowly in broth than did the streptomycin-susceptible ancestor, and the mutants were of diminished virulence. Growth curves determined in 90% normal mouse serum ( Fig. 1) showed that the two streptomycin-resistant strains tested (SW1444 and C5R), both nonvirulent, had longer doubling times than did the streptomycin-sensitive virulent strain C5 (the wild-type ancestor of C5P). These results are in agreement with those of Hobson (7) . The growth rate of the virulent strain C5P was low, even in serum supplemented with histidine (the growth requirement of C5P), but it is possible that with a larger supplement of histidine it would have doubled faster. In any case, the nonvirulence of the recombinant C5R was unlikely to be due to inheritance of the streptomycinresistance allele from the S. abony SW1444 donor, since some recombinants which inherited the same allele from SW1444 in crosses with another virulent subline of S. typhimurium C5 were still virulent (11) .
When bacteria are injected intravenously into normal mice, cells of strains which are nonvirulent (to the mouse) are in general rapidly removed from the circulation by phagocytosis, whereas cells of mouse-virulent strains are much less rapidly cleared. This has been shown with S. typhimurium (3, 8) , S. gallinarum (9) , and with Klebsiella pneumoniae (9) . Presumably, susceptibility to rapid clearance by phagocytosis is either the cause of the diminished virulence of the strains concerned, or it results in some way from the character, e.g., roughness, which causes their low virulence. But not all strains of low virulence for the mouse are rapidly cleared, because there are strains (Vi-negative) of S. typhi (5), S. adelaide (5, 10) , Escherichia coli 011OB4 (1), and S. paratyphi B (this paper) which are smooth and yet poorly phagocytized. These exceptions have been noted previously (3, 5) .
In the present study, clearance of intravenously inoculated viable bacteria was followed by making counts of viable bacteria in blood samples taken at short intervals after injection. When strains whose clearance in normal mice had been investigated by Jenkin (8) were tested in this way, the rates of clearance ("phagocytic indexes") determined from viable counts were essentially similar to those determined from clearance of radioactivity of intravenously inoculated viable bacteria labeled with "P (8; Fig. 2 ). We infer that the clearance (in terms of viable count) which we observed results, mainly or entirely, from removal by phagocytosis by fixed cells of the RES (liver and spleen mainly), rather than from killing in the bloodstream (e.g., phagocytosis by circulating leukocytes), and we have therefore calculated "phagocytic indexes." Earlier work cited above suggests that all Salmonella strains susceptible to rapid clearance are of low virulence, but that some (smooth) nonvirulent strains are not rapidly cleared. In the present work, the mouse-virulent (smooth) S. typhimurium parent strain C5P was, as expected, cleared very slowly in normal mice (K = 0.015; Fig. 2 ). The relatively nonvirulent S. abony parent SW1444, though smooth by the criteria used, was rapidly cleared (K = 0.137; Fig. 2 ) from such mice. Testing the virulence of recombinants from crosses of these two strains indicated that the low virulence of the S. abony parent (LD6o = 108 bacteria) was determined by the joint effect of two loci (chromosomal regions), one between inl and metA and the other between strA and aroD (11, 14, 17) . The presence of one only of these "low-virulence" loci in a recombinant results in intermediate virulence (LDOn = 10' bacteria), as shown previously (11) . The nonvirulent S. abony Hfr strain SW1444 is susceptible to rapid clearance, and it might therefore have been expected that one of the two "lowvirulence" loci determined the susceptibility to rapid clearance of strain SW1444 and thus its diminished virulence. However, the smooth recombinant CSR, obtained from a backcross in such a way that it had both the S. abony "lowvirulence" loci in an S. typhimurium genetic background, was as nonvirulent as the S. abony parent (LDIo = 108 bacteria; 11), but was no more rapidly cleared (K = 0.007; Fig. 2 ) than the virulent S. typhimurium parent C5P. It therefore appears that both of the "low-virulence" loci determine diminished virulence by mechanisms other than susceptibility to rapid clearance. The physiological basis and genetic determination of the susceptibility of SW1444 to phagocytosis remain unknown. It is therefore not yet feasible to test whether this character would by itself affect virulence (e.g., in a recombinant lacking the two mapped "low-virulence" loci). The slow clearance of the recombinant C5R presumably reflects inefficient phagocytosis (owing to limitation of antibody), since cells of C5R become susceptible to rapid clearance upon opsonization with immune serum (Table 3) .
Biozzi and his colleagues (3) reported that a nonvirulent E. coli-S. typhimurium recombinant was rapidly cleared from the blood, like its nonvirulent E. coli donor parent and unlike its virulent S. typhimurium recipient parent. Although the recombinant possessed the characteristic somatic and flagellar antigens of the virulent parent, minor differences in the surface antigens of such a recombinant and the recombinant C5R (described here) may account for the difference in behavior of the two types of recombinants in clearance tests.
The nonvirulent recombinant C5R and the virulent C5P were both poorly phagocytized initially in normal mice ( Fig. 2 and 3) , and we therefore made a study of later events in the hope of discovering which of these events were related to the final outcome of infection. When intravenous challenge doses were 5 X 107 to 10 x 107 viable bacteria, both C5P and C5R were slowly cleared from the mouse circulation but reemerged in the bloodstream after a variable time (Fig. 4) . The re-emergence was characteristic (i.e., occurred earlier with the virulent C5P than with the nonvirulent C5R), even though both of the strains finally killed their hosts. However, if the challenge dose was 5 X 10' to 10 x 105 bacteria, a different situation developed (Fig. 5) . The numbers of virulent C5P in the blood increased and the challenged mice died, but both of these events occurred later than in the experiments with the larger dose. There was no resurgence of the nonvirulent C5R, no bacteria were detectable in the blood 5 to 7 days after challenge (Fig. 5) , and all of the mice survived. This characteristic of a smaller dose level has previously been observed in the Salmonellamouse infection system (7) .
Prior to death of mice challenged intraperitoneally with small numbers of virulent S. typhimurium, the bacterial population in the organs (associated with bacteremia) amounts to in the case of mice dying from challenge with the virulent parent strain C5P (Fig. 5-7) . It may therefore be asssumed that death of animals infected with the virulent S. typhimurium was associated with marked bacterial proliferation. On the other hand, the nonvirulent recombinant C5R and the nonvirulent parent SW1444 failed to proliferate markedly (Fig. 5-7) . Similar observations have been made with a relatively nonvirulent, streptomycin-resistant mutant of S. typhimurium (7) .
One may conclude that the recombinant C5R lacks the ability to proliferate in the tissues of the mouse, presumably because it possesses one or both of the two "low-virulence" loci of its nonvirulent S. abony parent SW1444. This inability to proliferate is not related to nutritional requirement, because C5R is prototrophic, is not associated with loss of the smooth character (as determined in phage sensitivity tests), and does not result from susceptibility to rapid intravenous clearance.
